chitosan has been researched along with Lung Neoplasms in 146 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.68) | 18.2507 |
| 2000's | 17 (11.64) | 29.6817 |
| 2010's | 83 (56.85) | 24.3611 |
| 2020's | 45 (30.82) | 2.80 |
| Authors | Studies |
|---|---|
| Mahto, SK; Mehata, AK; Muthu, MS; Priya, V; Sharma, V; Varshney, N; Viswanadh, MK | 1 |
| Chen, H; Gao, Y; Li, Z; Wang, J; Zhang, L; Zhang, P; Zhu, L | 1 |
| Bai, H; Chen, Q; He, Y; Hu, J; Huang, G; Mao, J; Tang, G | 1 |
| Gupta, U; Kumar, V; Nakhate, KT; Rana, R; Rani, S | 1 |
| Masarudin, MJ; Yee Kuen, C | 1 |
| Abdel-Wahhab, MA; Badawy, AM; Badawy, EA; El-Bana, MA; El-Dosoky, MA; Farrag, AE; Mahmoud, MA; Morsy, SM | 1 |
| Chen, S; Ji, X; Jin, J; Zhang, H; Zhao, L; Zhao, M | 1 |
| El Gamal, DM; Khamis, AA; Mohamed, TM; Ragab, EM | 1 |
| Behera, C; Kumari, P; Mahto, SK; Mehata, AK; Muthu, MS; Suseela, MNL | 1 |
| Abu-Doleh, SM; Abuthawabeh, R; Al-Ali, S; Al-Tarawneh, SF; Alyami, H; Dahmash, EZ; Iyire, A | 1 |
| Bai, L; Guo, Y; Kuang, M; Liu, X; Luo, Y; Sun, M; Wang, B; Wang, C; Xie, J; Xu, M; Zhang, L | 1 |
| Brindhadevi, K; Chi, NTL; Garaleh, M; Garalleh, HA; Kaliannan, T; Pugazhendhi, A; Sathiyavimal, S; Sharma, A; Vasantharaj, S | 1 |
| Aldhahrani, A; Alharbi, NS; Althobaiti, F; El-Mehasseb, IM; El-Shafai, NM; Elnajjar, N; Sahyon, HA; Shoair, AGF | 1 |
| Hsu, SH; Xu, J; Yang, CS; Yin, AY | 1 |
| Aalhate, M; Dhuri, A; Gupta, U; Guru, SK; Mahajan, S; Maji, I; Parida, KK; Singh, H; Singh, PK; Sriram, A | 1 |
| Fu, X; Ju, Y; Kimura, Y; Song, G; Toku, Y | 1 |
| Hu, X; Li, W; Ma, H; Song, K; Sun, T; Wang, D; Wang, L; Wang, S; Wang, W; Wang, Y; Yang, J | 1 |
| Chen, H; Gao, Y; Long, H; Wang, J; Zhang, P; Zhu, F; Zhu, L | 1 |
| Amirishoar, M; Ganji, S; Jafari, SM; Jahedi, R; Kharazmi, MS; Narmani, A | 1 |
| Chawla, R; Kumar, A; Kumar, K; Mishra, M; Rawat, SG | 1 |
| Ajithkumar, V; Rajan, M; Uma Maheswari, RT; Varalakshmi, P | 1 |
| El-Mehasseb, IM; Elshami, FI; Shaban, SY; Shereef, HA; van Eldik, R | 1 |
| Chen, M; Chen, S; Liao, H; Niu, C; Tan, W; Xu, Y | 1 |
| Jia, R; Jia, Y; Liu, J; Taledaohan, A; Wang, X; Wang, Y | 1 |
| He, X; Lan, Y; Liang, Y; Liu, K; Xu, W; Zhang, W | 1 |
| Bharathi, D; Bhuvaneshwari, V; Chandarshekar, B; Ranjithkumar, R | 1 |
| Bai, H; Chen, Q; Chu, PK; Huang, G; Tang, G; Wang, J; Wu, W | 1 |
| Hsieh, MC; Huang, TW; Liao, LJ; Yen, CH; Young, TH | 1 |
| Banáth, J; Chen, WR; Gallagher, P; Hode, T; Korbelik, M; Lam, SSK; Zeng, H; Zhang, W; Zhao, J | 1 |
| Chen, T; Feng, J; Qi, N; Tu, L; Wang, G; Wu, W; Zhang, W | 1 |
| Choi, JH; Choi, YJ; Jeong, MS; Kim, MW; Kwon, SH; Lee, R; Motoyama, K; Park, YI | 1 |
| Abbas, SR; Sohail, R | 1 |
| Liu, AJ; Liu, C; Wu, P; Yu, SS | 1 |
| Chen, H; Gao, Y; Li, B; Li, X; Li, Z; Liu, W; Ye, J; Zheng, Y; Zhu, L | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Cheng, NC; Ji, YR; Li, ST; Wang, JH; Yen, CH; Young, TH | 1 |
| Chen, GP; Chen, ZT; Fang, CJ; Guo, Y; Hu, JJ; Huang, LM; Pang, XF; Qiu, D; Sun, JG; Zhang, Q; Zhu, HZ | 1 |
| Albiss, BA; Alnaief, M; Alsmadi, MM; Hailat, N; Obaidat, RM | 1 |
| Hu, X; Jeevithan, E; Mariadoss, AVA; Saravanakumar, K; Sathiyaseelan, A; Shin, S; Wang, MH | 1 |
| Alharbi, NS; Kadaikunnan, S; Khaled, JM; Li, JL; Li, WJ; Manoharan, N; Quero, F; Rajivgandhi, G; Ramachandran, G; Saravanan, K; Yin, L | 1 |
| Jha, A; Mahto, SK; Mehata, AK; Muthu, MS; Neogi, K; Poddar, S; Priya, V; Reddy Adena, SK; Viswanadh, MK | 1 |
| Chee, CF; Dabbagh, A; Rahman, NA; Rasul, RM; Shah, K; Tamilarasi Muniandy, M; Wong, TW; Zakaria, Z | 1 |
| Cui, X; Gai, C; Li, W; Wang, S; Wang, Y; Xu, Z; Yu, H; Zhang, W | 1 |
| Chen, Q; Jin, Q; Liu, Z; Shen, J; Yang, Y; Zhu, J; Zhu, W | 1 |
| Chen, MS; Gan, Y; Guo, LM; Miao, YQ; Wang, R; Zhang, XX; Zhou, X; Zhu, JJ | 1 |
| Huang, TW; Yen, CH; Young, TH | 1 |
| Deng, L; Fang, Z; Feng, L; Guo, R; Li, Y; Liu, Z; Qin, L; Wu, X; Yu, Z; Zheng, Y; Zhu, X | 1 |
| Ak, G | 1 |
| Kang, J; Shim, J; Yun, SI | 1 |
| Aghebati-Maleki, L; Baradaran, B; Hajivalili, M; Jadidi-Niaragh, F; Movassaghpour Akbari, AA; Pourgholi, F; Shabani, M; Shali, H; Younesi, V; Yousefi, M | 1 |
| Bai, A; Jiang, J; Liu, X; Liu, Y; Lv, H; Qiu, Y; Wu, C; Xu, X | 1 |
| Bharti, S; Koch, B; Muthu, MS; Pandey, BL; Sharma, G; Singh, RP; Singh, S | 1 |
| Fan, L; Jiang, K; Li, T; Shao, J; Zhao, R; Zheng, G | 1 |
| Awasthi, R; Bebawy, M; De Jesus Andreoli Pinto, T; Dua, K; Gupta, G; Hansbro, PM; Tekade, M; Tekade, RK | 1 |
| Gandee, L; Hernandez, E; Iyer, R; Kuriakose, A; Menon, JU; Nguyen, KT; Saha, D; Takahashi, M; Zhang, S; Zhang, Z | 1 |
| Biniecki, K; Buschmann, MD; Chevrier, A; Gopalakrishna Panicker, RK; Lavertu, M; Veilleux, D | 1 |
| Bao, J; Chen, M; Fa, H; Hou, C; Huo, D; Qi, Y; Yang, M; Zeng, Y; Zhao, Y | 1 |
| Balaraman Ravindrran, M; Dhanapal, J | 1 |
| Amighi, K; Gelbcke, M; Hecq, J; Mathieu, V; Mathivet, T; Rosière, R; Van Antwerpen, P; Van Woensel, M; Vermeersch, M; Wauthoz, N | 1 |
| Du, L; Lin, L; Shi, X; Wang, M; Xiao, Y; Zhu, X | 1 |
| Capel, V; Clarke, PA; Grabowska, AM; Luxton, D; Mantovani, G; Stolnik, S; Vllasaliu, D; Watts, P | 1 |
| Baran, T; Kaya, M; Sargin, I; Tan, G; Tevlek, A | 1 |
| Ajduković, JJ; Ignjatović, NL; Kojić, VV; Marković, SB; Penov-Gaši, KM; Uskoković, DP | 1 |
| Gao, Y; Jiang, J; Liu, Y; Tao, L; Wu, C | 1 |
| Du, L; Guo, X; Ji, T; Jia, H; Li, C; Li, H; Liu, Y; Wang, Y; Zhang, Y; Zhuang, Q | 1 |
| Cha, B; Hwang, SC; Jeong, YI; Kang, DH; Kim, J; Lee, HL; Nah, JW | 1 |
| Biswas, S; Ghosh, B; Muddineti, OS; Rompicharla, SVK; Shah, A | 1 |
| Baksi, R; Borse, SP; Nivsarkar, M; Rana, R; Sharma, V; Singh, DP | 1 |
| Chen, AZ; Kankala, RK; Pan, YJ; Wang, SB; Xu, PY; Yuan, H | 1 |
| Chen, W; Li, F; Li, J; Liu, Y; Qu, C; Yang, S; You, B; Yuan, Z; Zhang, X; Zhou, Y | 1 |
| Cheng, B; Gao, F; Maissy, E; Xu, P | 1 |
| Chen, YY; Huang, WT; Hung, CC; Lan, SJ; Lin, HY; Lin, YJ; Liu, DM; Sheu, MJ; Tu, YC | 1 |
| Chen, GP; Chen, ZT; Guo, Y; Hou, J; Jiang, FL; Liu, X; Pang, XF; Sun, JG; Zhu, HZ | 1 |
| Alex, VV; Anto, RJ; Antony, J; Kumar, GSV; Liju, VB; Nandan, CD; Retnakumari, AP; Shankar G, M; Somaraj, J; Sundaram, S; Thulasidasan, AT; Vijayakurup, V; Vinod, BS | 1 |
| Cho, HJ; Koo, JS; Lee, SY; Yang, M | 1 |
| Abd-Rabou, AA; Almutairi, FM; Mohamed, MS | 1 |
| Webster, TJ; Zhang, L | 1 |
| Alupei, MC; Astilean, S; Boca, S; Chiriac, MT; Damert, A; Licarete, E; Popescu, O; Potara, M; Schmidt, U | 1 |
| Fukushima, M; Hira, D; Kito, D; Oiwa, A; Okamoto, H; Okuda, T | 1 |
| Ishii, R; Nagaoka, N; Ogasawara, M; Shang, Y; Tagawa, Y; Tamai, M; Yang, J; Yoshida, Y | 1 |
| Chang, JB; Chen, YL; Chung, JG; Hung, FM; Hung, HF; Lu, HF; Shang, HS; Shih, YL; Wood, WG; Wu, MF; Yeh, C; Yeh, MY | 1 |
| Choi, K; Han, SJ; Jeong, SY; Kim, K; Kim, SH; Koo, H; Kwon, IC; Lee, S; Lee, SJ; Min, HS; Na, JH; Yun, SH | 1 |
| Jiang, X; Wang, X; Wu, W; Yang, C; Zhang, Y; Zhen, X | 1 |
| Jayakumar, R; Lakshmanan, VK; Maya, S; Menon, D; Sarmento, B; Seabra, V | 1 |
| Arora, K; Choudhary, M; Kaur, S; Singh, A | 1 |
| Cheng, J; Jiang, C; Sun, Z; Wang, F; Wang, H; Xie, H; Yu, B; Zhang, X; Zhou, L | 1 |
| Ma, JX; Qian, L; Zhou, Y | 1 |
| An, JH; Chen, GP; Chen, ZT; Han, J; Jiang, FL; Li, XT; Li, YS; Peng, LN; Sun, JG; Yao, Q; Zhu, HZ | 1 |
| Anaraki, NA; Ardeshirzadeh, B; Irani, M; Rad, LR; Shamshiri, S | 1 |
| Chiou, SH; Huang, WT; Larsson, M; Lin, HY; Liu, DM; Wang, YJ | 1 |
| Hirosue, M; Lehr, CM; Loretz, B; Nafee, N; Wenz, G | 1 |
| Birundha, K; Devi, KT; Kaveri, K; Kumar, SP | 1 |
| Han, B; Jiang, Z; Li, H; Li, X; Liu, W; Yang, Y | 1 |
| Arya, N; Katti, DS | 1 |
| Fujitaka, K; Hattori, N; Horimasu, Y; Ihara, D; Iwamoto, H; Kohno, N; Masuda, T; Nakashima, T; Okamoto, H; Senoo, T | 1 |
| Chen, WL; Li, JZ; Liu, C; Liu, Y; Yang, SD; Yuan, ZQ; Zhang, CG; Zhang, XN; Zhou, XF; Zhu, WJ | 1 |
| Amiji, MM; Bousbaa, H; Ferreira, D; Nascimento, AV; Sarmento, B; Singh, A | 2 |
| Gou, M; Li, X; Li, Z; Peng, F; Qian, Z; Sun, L | 1 |
| Amiji, MM; Bousbaa, H; Ferreira, D; Gattacceca, F; Nascimento, AV; Sarmento, B; Singh, A | 1 |
| Abbas, Y; Ali, ME; Azzazy, HM; Lamprecht, A; Mathur, S; Schmidt, A; Sollazzo, S; Tammam, S | 1 |
| Han, HW; Hsu, SH | 1 |
| Gajbhiye, V; Jain, NK; Kesharwani, P; Nag, M | 1 |
| Ahmadi, M; Baradaran, B; Esmaeili, S; Hajivalili, M; Mikaeili, H; Razavi, R; Sadreddini, S; Safaralizadeh, R; Seifi-Najmi, M; Shams-Asenjan, K; Yousefi, M | 1 |
| Chen, Y; Fan, J; Fu, SZ; Wang, SS; Wu, JB; Xu, S; Yang, JP; Yang, LL; Yun, Q | 1 |
| Chiou, GY; Huang, WT; Larsson, M; Lee, YC; Liu, DM | 1 |
| Ekgasit, S; Komenek, S; Luesakul, U; Muangsin, N; Praphairaksit, N; Puthong, S; Vilaivan, T | 1 |
| Cao, Y; Ma, Q; Wang, F; Wang, Y; Yu, B | 1 |
| Ahn, HJ; Byeon, Y; Han, HD; Jang, JH; Jeon, HN; Jung, ID; Kang, TH; Kim, GH; Kim, MG; Lee, JW; Lee, YJ; Lim, YT; Pack, CG; Park, YM; Shin, BC; Sood, AK | 1 |
| Jain, UK; Jyoti, K; Kaushik, D; Kush, P; Madan, J; Pandey, RS | 1 |
| Kim, JH; Kim, K; Koo, H; Kwon, IC; Lee, H; Lee, KY; Lee, S; Na, JH; Shim, MK; Shin, ML; Yoon, HY | 1 |
| Cai, X; Wang, Y; Wei, Z; Zhang, A; Zhang, J | 1 |
| Chen, FY; Du, YZ; Hu, FQ; Wu, QA; Ye, YQ; Yu, HY; Yuan, H | 1 |
| Cheng, G; Chung, SJ; Cui, F; Kim, DD; Kim, IW; Shim, CK; Shim, WS; Yang, R; Yang, SG | 1 |
| Baldes, C; Beisner, J; Huwer, H; Klotz, U; Lehr, CM; Mürdter, TE; Nafee, N; Piotrowska, K; Schaefer, UF; Schneider, M; Taetz, S | 1 |
| Luo, X; Pan, SR; Wang, C; Zhang, W; Zhang, X | 1 |
| Cheng, G; Chung, SJ; Cui, FD; Han, X; Jin, QR; Kim, DD; Shim, CK; Shim, WS; Yang, R | 1 |
| Arote, R; Cho, CS; Cho, MH; Choi, YJ; Jere, D; Jiang, HL; Kim, YK; Yun, CH | 1 |
| Choong, PF; Dass, CR; Dunstan, DE; Larson, I; Ta, HT | 1 |
| Arote, R; Cho, CS; Cho, MH; Jere, D; Jiang, HL; Kim, YK; Lim, HT; Xu, CX | 1 |
| Hirashima, N; Kawashima, Y; Sakai, T; Tahara, K; Takeuchi, H; Yamamoto, H | 1 |
| Jon, S; Kim, H; Lee, E; Lee, IH | 1 |
| Baek, KH; Choi, JJ; Han, SE; Huh, JH; Kim, JS; Kim, K; Kim, MS; Kwon, IC; Lee, HY; Noh, SM; Oh, YK; Park, MO; Shim, G | 1 |
| Beppu, MM; Cohen, RE; Rubner, MF; Swiston, AJ; Vasconcellos, FC | 1 |
| Hennink, WE; Lammers, T; Schiffelers, RM; Storm, G; Varkouhi, AK; Verheul, RJ | 1 |
| Danjo, K; Okamoto, H; Shiraki, K; Watanabe, Y; Yasuda, R | 1 |
| Mehrotra, A; Nagarwal, RC; Pandit, JK | 1 |
| Cannavà, C; Cosco, D; La Mantia, A; Paolino, D; Pignatello, R; Stancanelli, R; Tommasini, S; Ventura, CA | 1 |
| Ammon-Treiber, S; Dong, M; Friedel, G; Griese, EU; Klotz, U; Lehr, CM; Loretz, B; Mürdter, TE; Nafee, N; Philippi, C; Schaefer, UF | 1 |
| Lv, PP; Ma, GH; Wang, LY; Wei, W; Yang, TY; Yue, H | 1 |
| Azadmanesh, K; Gilani, K; Moazeni, E; Mohajel, N; Najafabadi, AR; Rahimi, A; Vatanara, A | 1 |
| Dong, M; Friebel, K; Lehr, CM; Mürdter, TE; Nafee, N; Schaefer, UF; Schneider, M | 1 |
| Lv, PP; Ma, GH; Ma, YF; Ni, DZ; Wei, W; Yu, R; Yue, H | 1 |
| Cai, LL; Du, YZ; Jie, LY; Wang, LJ; Ying, XY; Yu, RS; Zhang, MM | 1 |
| Arya, N; Katti, DS; Rangarajan, A; Sardana, V; Saxena, M | 1 |
| Bao, X; Du, YZ; Hu, FQ; You, J; Yuan, H | 1 |
| Dass, CR; Friedhuber, AM; Tan, ML | 1 |
| Deng, H; Lei, Z; Li, W; Li, X; Xin, S; Zhang, T; Zhou, X; Zhu, Y | 1 |
| Hu, FQ; Wan, LQ; Yuan, H | 1 |
| Anderson, HK; Chang, SH; Cho, CS; Cho, MH; Colburn, NH; Hwang, SK; Jin, H; Kim, HW; Kim, TH; Lee, HW; Lee, KH; Yang, HS | 1 |
| Andersen, MØ; Besenbacher, F; Dong, M; Hansen, OC; Howard, KA; Johnsen, MG; Kjems, J; Liu, X; Rahbek, UL | 1 |
| Choong, PF; Contreras, KG; Dass, CR; Dunstan, DE | 1 |
| Aiello, C; Bignardi, G; Cafaggi, S; Caviglioli, G; De Totero, D; Leardi, R; Parodi, B; Russo, E; Stefani, R; Viale, M | 1 |
| Lehr, CM; Nafee, N; Schaefer, UF; Schneider, M; Taetz, S | 1 |
| Chang, SH; Cho, CS; Cho, MH; Chung, YS; Hwang, SK; Jin, H; Kim, DY; Kim, HW; Kim, TH; Kwon, JT; Lee, ES; Lee, KH; Minai-Tehrani, A; Noh, MS; Park, SJ; Shin, JY; Woo, M; Xu, CX; Yoon, BI; Youn, HJ | 1 |
| Hojo, K; Kamada, H; Kawasaki, K; Kurita, K; Mayumi, T; Nishiyama, Y; Tsutsumi, Y; Yoshikawa, T | 1 |
5 review(s) available for chitosan and Lung Neoplasms
| Article | Year |
|---|---|
Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment.
Topics: Animals; Chitosan; Delayed-Action Preparations; Drug Liberation; Drug Resistance, Multiple; Humans; Lung Neoplasms; Nanoparticles | 2022 |
Therapeutic potential of chrysin nanoparticle-mediation inhibition of succinate dehydrogenase and ubiquinone oxidoreductase in pancreatic and lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Chitosan; Flavonoids; Humans; Lung Neoplasms; Nanoparticles; Pancreatic Neoplasms; Succinate Dehydrogenase; Ubiquinone | 2022 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers.
Topics: Anti-Infective Agents; Antineoplastic Agents; Betacoronavirus; Biocompatible Materials; Cell Survival; Chitosan; Coronavirus Infections; COVID-19; Drug Carriers; Humans; Lung Neoplasms; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
Topics: Animals; Asthma; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Humans; Lung Neoplasms; Nanoparticles; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Respiration Disorders; Respiratory Tract Infections | 2017 |
1 trial(s) available for chitosan and Lung Neoplasms
141 other study(ies) available for chitosan and Lung Neoplasms
| Article | Year |
|---|---|
Bioadhesive chitosan nanoparticles: Dual targeting and pharmacokinetic aspects for advanced lung cancer treatment.
Topics: A549 Cells; Animals; Chitosan; Docetaxel; Drug Carriers; Humans; Lung Neoplasms; Nanoparticles; Rats; Rats, Wistar | 2021 |
An intelligent hypoxia-relieving chitosan-based nanoplatform for enhanced targeted chemo-sonodynamic combination therapy on lung cancer.
Topics: A549 Cells; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chitosan; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Molecular Targeted Therapy | 2021 |
Chitosan-derived nanoparticles impede signal transduction in T790M lung cancer therapy.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Mice; MicroRNAs; Mutation; Nanoparticles; Protein Kinase Inhibitors; Signal Transduction | 2021 |
Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Chitosan; Drug Carriers; Lung Neoplasms; N-Acetylneuraminic Acid; Nanoparticles; Rats; Rats, Sprague-Dawley | 2021 |
Synthesis and characterization of berberine-loaded chitosan nanoparticles for the protection of urethane-induced lung cancer.
Topics: Animals; bcl-2-Associated X Protein; Berberine; Caspase 9; Chitosan; Lung Neoplasms; Male; Mice; Nanoparticles; Urethane | 2022 |
Construction of chitooligosaccharide-based nanoparticles of pH/redox cascade responsive for co-loading cyclosporin A and AZD9291.
Topics: Acrylamides; Aniline Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Cyclosporine; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Indoles; Lung Neoplasms; Nanoparticles; Oligosaccharides; Oxidation-Reduction; Pyrimidines; Tumor Microenvironment | 2022 |
Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model.
Topics: Alginates; Animals; Cell Line, Tumor; Chitosan; Folic Acid; Lung Neoplasms; Mice; Nanoparticles; Rats; Rats, Wistar | 2022 |
Mechanistic modelling of targeted pulmonary delivery of dactinomycin iron oxide-loaded nanoparticles for lung cancer therapy.
Topics: Administration, Inhalation; Alginates; Chitosan; COVID-19; Dactinomycin; Drug Delivery Systems; Humans; Lung; Lung Neoplasms; Nanoparticles; Respiratory Aerosols and Droplets | 2022 |
Nanoemulsion Co-Loaded with XIAP siRNA and Gambogic Acid for Inhalation Therapy of Lung Cancer.
Topics: Antineoplastic Agents; Chitosan; Humans; Lung Neoplasms; Respiratory Therapy; RNA, Small Interfering; X-Linked Inhibitor of Apoptosis Protein | 2022 |
Bio-functionalized copper oxide/chitosan nanocomposite using Sida cordifolia and their efficient properties of antibacterial, anticancer activity against on breast and lung cancer cell lines.
Topics: Anti-Bacterial Agents; Bacteria; Cell Line; Chitosan; Copper; Humans; Lung Neoplasms; Metal Nanoparticles; Microbial Sensitivity Tests; Nanocomposites; Spectroscopy, Fourier Transform Infrared; Water; X-Ray Diffraction | 2023 |
Avocado peel extract loaded on chitosan nanoparticles alleviates urethane toxicity that causes lung cancer in a mouse model.
Topics: Animals; Chitosan; Humans; Lung Neoplasms; Mice; Nanoparticles; Persea; Plant Extracts; Urethane | 2023 |
Antiviral and Antibacterial Sulfated Polysaccharide-Chitosan Nanocomposite Particles as a Drug Carrier.
Topics: Anti-Bacterial Agents; Antiviral Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Nanoparticles; Polysaccharides; Sulfates | 2023 |
Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy.
Topics: Carcinoma, Non-Small-Cell Lung; Chitosan; Drug Carriers; Humans; Lung; Lung Neoplasms; Nanoparticles; Polyesters; Tyrosine Kinase Inhibitors | 2023 |
Metabolic dependency of non-small cell lung cancer cells affected by three-dimensional scaffold and its stiffness.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chitosan; Collagen; Humans; Lung Neoplasms; Tissue Scaffolds; Tumor Microenvironment | 2023 |
A decellularized lung extracellular matrix/chondroitin sulfate/gelatin/chitosan-based 3D culture system shapes breast cancer lung metastasis.
Topics: Animals; Chitosan; Chondroitin Sulfates; Extracellular Matrix; Gelatin; Lung; Lung Neoplasms; Swine; Tissue Scaffolds | 2023 |
Study of the mechanism of ultrasound-induced enhanced therapeutic effects of a chitosan-based nanoplatform.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Humans; Lung Neoplasms; Nanoparticles | 2023 |
Smart chitosan-PLGA nanocarriers functionalized with surface folic acid ligands against lung cancer cells.
Topics: Chitosan; Drug Carriers; Folic Acid; Glycols; Humans; Ligands; Lung Neoplasms; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer | 2023 |
Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cetuximab; Chitosan; ErbB Receptors; Gemcitabine; Hydrogen-Ion Concentration; Lung Neoplasms; Mice; N-Acetylneuraminic Acid; Nanoparticles | 2023 |
CD44 tagged hyaluronic acid - chitosan liposome carrier for the delivery of berberine and doxorubicin into lung cancer cells.
Topics: Animals; Berberine; Caenorhabditis elegans; Chitosan; Doxorubicin; Drug Delivery Systems; Humans; Hyaluronan Receptors; Hyaluronic Acid; Liposomes; Lung Neoplasms; Nanoparticles | 2023 |
Hydroxychloroquine-Loaded Chitosan Nanoparticles Induce Anticancer Activity in A549 Lung Cancer Cells: Design, BSA Binding, Molecular Docking, Mechanistic, and Biological Evaluation.
Topics: Anti-Bacterial Agents; Chitosan; Drug Liberation; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hydroxychloroquine; Lung Neoplasms; Molecular Docking Simulation; Nanoparticles | 2023 |
Temperature-Sensitive Nanocarbon Hydrogel for Photothermal Therapy of Tumors.
Topics: Animals; Chitosan; Hydrogels; Lung Neoplasms; Mice; Photothermal Therapy; Temperature | 2023 |
Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis.
Topics: Animals; Chitosan; Lung Neoplasms; Mice; Nanomedicine; Neutrophils; Oligopeptides; Protein-Arginine Deiminase Type 4; Tumor Microenvironment | 2023 |
Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chitosan; Female; Fluorescence; Gene Silencing; Humans; Hyaluronan Receptors; Hyaluronic Acid; Lung Neoplasms; Mice, Inbred BALB C; Nanoparticles; RNA, Small Interfering | 2019 |
Bio-inspired synthesis of chitosan/copper oxide nanocomposite using rutin and their anti-proliferative activity in human lung cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Chitosan; Copper; Humans; Lung Neoplasms; Nanocomposites; Rutin | 2019 |
Reconstructed chitosan with alkylamine for enhanced gene delivery by promoting endosomal escape.
Topics: A549 Cells; Amines; Animals; Cell Survival; Chitosan; DNA; Endocytosis; Endosomes; Erythrocytes; Female; Gene Transfer Techniques; HEK293 Cells; Hemolysis; Humans; Lung Neoplasms; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; RNA, Small Interfering; Tumor Suppressor Protein p53 | 2020 |
Increased Cell Detachment Ratio of Mesenchymal-Type Lung Cancer Cells on pH-Responsive Chitosan through the β3 Integrin.
Topics: A549 Cells; Biological Assay; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Chitosan; Epithelial-Mesenchymal Transition; Humans; Hydrogen-Ion Concentration; Integrin beta3; Lung Neoplasms; Signal Transduction; Transforming Growth Factor beta1 | 2019 |
N-dihydrogalactochitosan-supported tumor control by photothermal therapy and photothermal therapy-generated vaccine.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Caspase 1; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Chitosan; Disease Models, Animal; Fas Ligand Protein; fas Receptor; Fluorescein; Lasers, Semiconductor; Lung Neoplasms; Mice; Phototherapy; T-Lymphocytes, Regulatory | 2020 |
Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Micelles; Paclitaxel; Polymers; Rats; Solubility | 2020 |
Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer.
Topics: A549 Cells; Animals; Biological Transport; Carcinoma, Non-Small-Cell Lung; Celecoxib; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Gene Expression Regulation, Neoplastic; Humans; Hyaluronic Acid; Lung Neoplasms; Mice; Nanoparticles; Xenograft Model Antitumor Assays | 2020 |
Evaluation of amygdalin-loaded alginate-chitosan nanoparticles as biocompatible drug delivery carriers for anticancerous efficacy.
Topics: Amygdalin; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Materials Testing; Nanoparticles | 2020 |
Seleno-Chitosan induces apoptosis of lung cancer cell line SPC-A-1 via Fas/FasL pathway.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Fas Ligand Protein; fas Receptor; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Organoselenium Compounds; Signal Transduction | 2020 |
Near-infrared/pH dual-responsive nanocomplexes for targeted imaging and chemo/gene/photothermal tri-therapies of non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Combined Modality Therapy; Drug Carriers; Erlotinib Hydrochloride; Female; Fluorescent Dyes; Gene Transfer Techniques; Humans; Indoles; Infrared Rays; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photothermal Therapy; Plasmids; Precision Medicine; RNA, Small Interfering; Survivin; Xenograft Model Antitumor Assays | 2020 |
Label-free platform on pH-responsive chitosan: Adhesive heterogeneity for cancer stem-like cell isolation from A549 cells via integrin β4.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Separation; Chitosan; Female; Humans; Hydrogen-Ion Concentration; Integrin beta4; Lung Neoplasms; Mice; Mice, Nude; Neoplasms, Experimental; Neoplastic Stem Cells; Particle Size; Surface Properties; Tumor Cells, Cultured | 2020 |
Detection of miR-155-5p and imaging lung cancer for early diagnosis: in vitro and in vivo study.
Topics: A549 Cells; Animals; Chitosan; Early Detection of Cancer; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Nude; Mice, Transgenic; MicroRNAs; Molecular Imaging; Molecular Probes; Nanotechnology | 2020 |
Development, In Vitro Characterization, and In Vivo Toxicity Evaluation of Chitosan-Alginate Nanoporous Carriers Loaded with Cisplatin for Lung Cancer Treatment.
Topics: Administration, Inhalation; Alginates; Animals; Antineoplastic Agents; Chitosan; Cisplatin; Drug Carriers; Drug Development; Lung Neoplasms; Nanopores; Particle Size; Polymers; Porosity; Rats; Solubility | 2020 |
Dual stimuli-responsive release of aptamer AS1411 decorated erlotinib loaded chitosan nanoparticles for non-small-cell lung carcinoma therapy.
Topics: A549 Cells; Animals; Apoptosis; Aptamers, Nucleotide; Carcinoma, Non-Small-Cell Lung; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Nanoparticles; NIH 3T3 Cells; Oligodeoxyribonucleotides; Reactive Oxygen Species; Signal Transduction | 2020 |
Enhanced anti-cancer activity of chitosan loaded Morinda citrifolia essential oil against A549 human lung cancer cells.
Topics: A549 Cells; Antineoplastic Agents; Cell Cycle Checkpoints; Chemical Phenomena; Chitosan; Flow Cytometry; Gas Chromatography-Mass Spectrometry; Humans; Lung Neoplasms; Mitochondria; Morinda; Oils, Volatile; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; X-Ray Diffraction | 2020 |
Formulation and
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cetuximab; Chitosan; Docetaxel; Drug Carriers; Humans; Lung Neoplasms; Nanomedicine; Nanoparticles | 2020 |
Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Lung Neoplasms; Nanoparticles; Paclitaxel; Prospective Studies; Quercetin | 2021 |
Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis.
Topics: Administration, Inhalation; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Biological Transport; CD8-Positive T-Lymphocytes; Chitosan; Drug Liberation; Female; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mucins; N-Acetylneuraminic Acid; Nanocapsules; Protein Multimerization; Signal Transduction | 2021 |
Chitosan oligosaccharide modified liposomes enhance lung cancer delivery of paclitaxel.
Topics: A549 Cells; Animals; Antineoplastic Agents; Chitosan; Drug Carriers; Drug Liberation; Humans; Liposomes; Lung; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Oligosaccharides; Paclitaxel | 2021 |
Cell detachment ratio on pH-responsive chitosan: A useful biometric for prognostic judgment and drug efficacy assessment in oncology.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Chitosan; Female; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Medical Oncology; Mice; Mice, Nude; Particle Size; Prognosis; Treatment Outcome; Xenograft Model Antitumor Assays | 2021 |
Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Curcumin; Docetaxel; Drug Carriers; Drug Liberation; Humans; Hydrogen-Ion Concentration; Lung; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages; Mice; Myeloid-Derived Suppressor Cells; Nanoparticles; Reactive Oxygen Species; T-Lymphocytes; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2021 |
Covalently coupling doxorubicin to polymeric nanoparticles as potential inhaler therapy:
Topics: A549 Cells; Administration, Inhalation; Alginates; Antibiotics, Antineoplastic; Chitosan; Doxorubicin; Humans; Lung Neoplasms; Nanoparticle Drug Delivery System; Polyethylene Glycols | 2021 |
Chitosan-dipeptide hydrogels as potential anticancer drug delivery systems.
Topics: A549 Cells; Antibiotics, Antineoplastic; Cell Survival; Chitosan; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Hydrogels; Hydrogen-Ion Concentration; Lung Neoplasms; Phenylalanine | 2021 |
Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line.
Topics: A549 Cells; Apoptosis; Cell Movement; Chitosan; Down-Regulation; Doxorubicin; Drug Carriers; Drug Liberation; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Matrix Metalloproteinase 9; Nanoparticles; Neoplasm Invasiveness; Receptor, IGF Type 1; RNA, Small Interfering; STAT3 Transcription Factor; Vascular Endothelial Growth Factor A | 2018 |
Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells.
Topics: A549 Cells; Antineoplastic Agents; Biological Availability; Calorimetry, Differential Scanning; Cell Survival; Chitosan; Drug Delivery Systems; Humans; Lung; Lung Neoplasms; Nanoparticles; Nanospheres; Paclitaxel; X-Ray Diffraction | 2017 |
Chitosan-folate decorated carbon nanotubes for site specific lung cancer delivery.
Topics: Chitosan; Folic Acid; Humans; Lung; Lung Neoplasms; Nanotubes, Carbon | 2017 |
Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Delayed-Action Preparations; Disaccharides; Drug Synergism; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Lung Neoplasms; Male; Mice; Nanoparticles; Niacinamide; Phenylurea Compounds; Porosity; Rats; Silicon Dioxide; Sorafenib; Triterpenes; Ursolic Acid | 2017 |
Dual-Drug Containing Core-Shell Nanoparticles for Lung Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles | 2017 |
Lyophilisation and concentration of chitosan/siRNA polyplexes: Influence of buffer composition, oligonucleotide sequence, and hyaluronic acid coating.
Topics: Buffers; Carcinoma, Non-Small-Cell Lung; Chitosan; Freeze Drying; Green Fluorescent Proteins; Hemagglutination; Hemolysis; Humans; Hyaluronic Acid; Lung Neoplasms; Nanoparticles; Oligonucleotides; RNA, Small Interfering; Tumor Cells, Cultured | 2018 |
A sandwich-type electrochemical immunoassay for ultrasensitive detection of non-small cell lung cancer biomarker CYFRA21-1.
Topics: Amination; Antibodies, Immobilized; Antigens, Neoplasm; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chitosan; Conductometry; Dielectric Spectroscopy; Equipment Design; Graphite; Humans; Immunoassay; Keratin-19; Limit of Detection; Lung Neoplasms; Nanotubes, Carbon | 2018 |
Chitosan/poly (lactic acid)-coated piceatannol nanoparticles exert an in vitro apoptosis activity on liver, lung and breast cancer cell lines.
Topics: Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Chitosan; DNA Fragmentation; Drug Carriers; Drug Liberation; Humans; Liver; Lung Neoplasms; MCF-7 Cells; Nanoparticles; Nitric Oxide; Picrates; Polyesters; Stilbenes; Superoxide Dismutase | 2018 |
New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
Topics: Administration, Inhalation; Albumins; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Compounding; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Lipids; Lung; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Polyethylene Glycols; Surface Properties; Tissue Distribution; Xenograft Model Antitumor Assays | 2018 |
A Microfluidic Chip Integrated with Hyaluronic Acid-Functionalized Electrospun Chitosan Nanofibers for Specific Capture and Nondestructive Release of CD44-Overexpressing Circulating Tumor Cells.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Female; Glutathione; Humans; Hyaluronan Receptors; Hyaluronic Acid; Lung Neoplasms; Microfluidic Analytical Techniques; Nanofibers; Neoplastic Cells, Circulating | 2018 |
Water-soluble substituted chitosan derivatives as technology platform for inhalation delivery of siRNA.
Topics: A549 Cells; Administration, Inhalation; Animals; Chitosan; Drug Delivery Systems; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; RNA, Small Interfering; Solubility; Water; Xenograft Model Antitumor Assays | 2018 |
Antitumor activity of chitosan from mayfly with comparison to commercially available low, medium and high molecular weight chitosans.
Topics: A549 Cells; Acetylation; Animals; Apoptosis; Cell Proliferation; Chitin; Chitosan; Ephemeroptera; Humans; Lung Neoplasms; Molecular Weight | 2018 |
The effect of the androstane lung cancer inhibitor content on the cell-selective toxicity of hydroxyapatite-chitosan-PLGA nanocomposites.
Topics: A549 Cells; Androstanes; Calorimetry, Differential Scanning; Cell Line; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Durapatite; Humans; Lactic Acid; Lung Neoplasms; Microscopy, Atomic Force; Nanocomposites; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared | 2018 |
Biodegradable Alginate-Chitosan Hollow Nanospheres for Codelivery of Doxorubicin and Paclitaxel for the Effect of Human Lung Cancer A549 Cells.
Topics: A549 Cells; Alginates; Chitosan; Doxorubicin; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Humans; Lung Neoplasms; Nanospheres; Paclitaxel | 2018 |
Multi-functionalized chitosan nanoparticles for enhanced chemotherapy in lung cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Drug Carriers; Female; Humans; Lung Neoplasms; Methotrexate; Mice; Mice, Inbred BALB C; Nanoparticles | 2018 |
Redox- and pH-Responsive Nanoparticles Release Piperlongumine in a Stimuli-Sensitive Manner to Inhibit Pulmonary Metastasis of Colorectal Carcinoma Cells.
Topics: A549 Cells; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Colorectal Neoplasms; Dioxolanes; Drug Carriers; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Nanoparticles; Oxidation-Reduction; Polyethylene Glycols | 2018 |
Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells.
Topics: A549 Cells; Chitosan; Cholesterol; Curcumin; Drug Carriers; Humans; Lung Neoplasms; RNA, Small Interfering | 2018 |
In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Topics: A549 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Female; Humans; Kinetics; Lung Neoplasms; Male; Mice, Inbred C57BL; Nanomedicine; Nanoparticles; Quercetin; Solubility; Superoxide Dismutase; Technology, Pharmaceutical; Tissue Distribution; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chitosan; Doxorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Nanoparticles; RNA, Small Interfering; Tumor Cells, Cultured | 2018 |
A Novel 3D in Vitro Tumor Model Based on Silk Fibroin/Chitosan Scaffolds To Mimic the Tumor Microenvironment.
Topics: A549 Cells; Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Cell Movement; Chitosan; Drug Delivery Systems; Drug Evaluation, Preclinical; Fibroins; Humans; Lung Neoplasms; Microscopy, Confocal; Neoplasm Invasiveness; Porosity; Tissue Scaffolds; Tumor Microenvironment | 2018 |
Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles.
Topics: Animals; Cell Line, Tumor; Chitosan; Doxorubicin; Female; Human Umbilical Vein Endothelial Cells; Humans; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Suramin; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2019 |
Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chitosan; Cisplatin; Curcumin; Diarylheptanoids; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Microscopy, Confocal; Nanoparticles; Proto-Oncogene Proteins c-akt | 2018 |
Identification and imaging of miR-155 in the early screening of lung cancer by targeted delivery of octreotide-conjugated chitosan-molecular beacon nanoparticles.
Topics: A549 Cells; Animals; Chitosan; Drug Carriers; Early Detection of Cancer; Flow Cytometry; Humans; Lung Neoplasms; Mice, Nude; Mice, Transgenic; MicroRNAs; Microscopy, Confocal; Molecular Imaging; Nanoparticles; Octreotide; Receptors, Somatostatin; Xenograft Model Antitumor Assays | 2018 |
Chitosan Encapsulation Enhances the Bioavailability and Tissue Retention of Curcumin and Improves its Efficacy in Preventing B[a]P-induced Lung Carcinogenesis.
Topics: Animals; Antineoplastic Agents; Benzo(a)pyrene; Biological Availability; Chitosan; Curcumin; Lung Neoplasms; Male; Mice; Nanoparticles | 2019 |
Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Humans; Lung Neoplasms; Melanoma; Mice; Nanoparticles; Neoplasm Metastasis; Optical Imaging; Particle Size; Phloretin; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2019 |
Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Humans; Hyaluronic Acid; Lung Neoplasms; Malondialdehyde; Nanoparticles; Nitric Oxide; Particle Size; Raloxifene Hydrochloride | 2019 |
Effects of chemically modified nanostructured PLGA on functioning of lung and breast cancer cells.
Topics: Alginates; Analysis of Variance; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Female; Glucuronic Acid; Hexuronic Acids; Humans; Lactic Acid; Lung Neoplasms; Nanostructures; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2013 |
Chitosan-coated triangular silver nanoparticles as a novel class of biocompatible, highly sensitive plasmonic platforms for intracellular SERS sensing and imaging.
Topics: Cell Line, Tumor; Chitosan; Coated Materials, Biocompatible; Humans; Lung Neoplasms; Materials Testing; Metal Nanoparticles; Silver; Spectrum Analysis, Raman | 2013 |
Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique.
Topics: Animals; Carbon Dioxide; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Compounding; Drug Stability; Dry Powder Inhalers; Gene Silencing; Luciferases, Firefly; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Particle Size; RNA, Small Interfering; Surface Properties; Tissue Distribution | 2013 |
Hybrid sponge comprised of galactosylated chitosan and hyaluronic acid mediates the co-culture of hepatocytes and endothelial cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Biocompatible Materials; Biomarkers; Cell Adhesion; Cells, Cultured; Chitosan; Coculture Techniques; Galactose; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Scanning; RNA, Messenger; Spectroscopy, Fourier Transform Infrared; Testosterone; Tissue Engineering; Tissue Scaffolds | 2014 |
Effects of chitosan on xenograft models of melanoma in C57BL/6 mice and hepatoma formation in SCID mice.
Topics: Animals; Carcinoma, Hepatocellular; Chelating Agents; Chitosan; Heterografts; Liver Neoplasms; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, SCID; Survival Rate; Tumor Burden; Tumor Cells, Cultured | 2013 |
Chemical tumor-targeting of nanoparticles based on metabolic glycoengineering and click chemistry.
Topics: Animals; Azides; Cell Line, Tumor; Chitosan; Click Chemistry; Hexosamines; Humans; Hydrophobic and Hydrophilic Interactions; Lung Neoplasms; Male; Mice; Molecular Targeted Therapy; Nanoparticles | 2014 |
Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticles.
Topics: Animals; Antineoplastic Agents; Capillary Permeability; Cell Death; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Delivery Systems; Endocytosis; Fluorescein-5-isothiocyanate; Humans; Lung Neoplasms; Male; Mice, Inbred ICR; Nanoparticles; Oligopeptides; Particle Size; Platinum; Spectroscopy, Near-Infrared; Spheroids, Cellular; Subcutaneous Tissue; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
Chitosan cross-linked docetaxel loaded EGF receptor targeted nanoparticles for lung cancer cells.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Death; Cell Line, Tumor; Cetuximab; Chitosan; Docetaxel; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Molecular Targeted Therapy; Nanoparticles; NIH 3T3 Cells; Polyglutamic Acid; Taxoids | 2014 |
Enhancing lung cancer diagnosis: electrochemical simultaneous bianalyte immunosensing using carbon nanotubes-chitosan nanocomposite.
Topics: Antigens, Neoplasm; Biosensing Techniques; Chitosan; Graphite; Humans; Lung Neoplasms; Microscopy, Electron, Scanning; Nanocomposites; Nanotubes, Carbon; Neoplasm Proteins; Spectroscopy, Fourier Transform Infrared | 2014 |
Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chitin; Chitosan; Delayed-Action Preparations; Deoxycholic Acid; Drug Carriers; Drug Compounding; Female; Humans; Lung Neoplasms; Male; Mice, Nude; Micelles; Nanoparticles; Oligosaccharides; Paclitaxel; Polyesters; Polyethylene Glycols; Random Allocation; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Surface Properties; Tumor Burden; Xenograft Model Antitumor Assays; Zebrafish | 2014 |
Stimulation effect of chitosan on the immunity of radiotherapy patients suffered from lung cancer.
Topics: Administration, Oral; Antigens, CD; Chitosan; Humans; Interleukin-6; Killer Cells, Natural; Lung Neoplasms; Radiation-Sensitizing Agents; Tumor Necrosis Factor-alpha; Water | 2015 |
Chitosan combined with molecular beacon for mir-155 detection and imaging in lung cancer.
Topics: Cell Line, Tumor; Chitosan; Flow Cytometry; Humans; Lung Neoplasms; MicroRNAs; Microscopy, Confocal; Molecular Imaging; Nanoparticles | 2014 |
Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Doxorubicin; Drug Screening Assays, Antitumor; Graphite; Humans; Lung Neoplasms; Nanocomposites; Nanofibers; Polyethylene Glycols | 2015 |
Demethoxycurcumin-carrying chitosan-antibody core-shell nanoparticles with multitherapeutic efficacy toward malignant A549 lung tumor: from in vitro characterization to in vivo evaluation.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Curcumin; Cytoplasm; Diarylheptanoids; Drug Carriers; Drug Delivery Systems; ErbB Receptors; Humans; Inhibitory Concentration 50; Light; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanomedicine; Nanoparticles; Neoplasm Transplantation; Scattering, Radiation | 2015 |
Cyclodextrin-based star polymers as a versatile platform for nanochemotherapeutics: Enhanced entrapment and uptake of idarubicin.
Topics: Antibiotics, Antineoplastic; Caco-2 Cells; Cell Survival; Cellulose; Chitosan; Cyclodextrins; Drug Carriers; Humans; Idarubicin; L-Lactate Dehydrogenase; Lung Neoplasms; Nanoparticles; Nanotechnology; Particle Size; Polyethylene Glycols; Tumor Cells, Cultured | 2015 |
Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Chitosan; Drug Compounding; Drug Liberation; Flavanones; Humans; Lung Neoplasms; Mice; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared | 2015 |
Preparation and anti-tumor metastasis of carboxymethyl chitosan.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Chitosan; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Matrix Metalloproteinase 9; Mice; Vascular Endothelial Growth Factor A | 2015 |
Poly(d,l-lactide-co-glycolide)-chitosan composite particles for the treatment of lung cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Drug Synergism; Humans; Lactic Acid; Lung Neoplasms; Nanocomposites; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Topotecan | 2015 |
Histological Quantification of Gene Silencing by Intratracheal Administration of Dry Powdered Small-Interfering RNA/Chitosan Complexes in the Murine Lung.
Topics: Administration, Inhalation; Animals; Cell Line, Tumor; Chitosan; Female; Green Fluorescent Proteins; Lung; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Transgenic; Powders; RNA Interference; RNA, Small Interfering; Trachea | 2015 |
Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chitosan; Drug Delivery Systems; Female; Humans; Lung Neoplasms; Mice, Nude; Micelles; Microtubules; Paclitaxel; Peptides, Cyclic; Tumor Burden | 2015 |
Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer Cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chitosan; Cisplatin; Drug Delivery Systems; ErbB Receptors; Humans; Lipids; Lung Neoplasms; Nanoparticles; Organoplatinum Compounds; Polyethylene Glycols; Small Molecule Libraries | 2015 |
Improving Antitumor Activity with N-Trimethyl Chitosan Entrapping Camptothecin in Colon Cancer and Lung Cancer.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Colonic Neoplasms; Drug Carriers; Female; Lung Neoplasms; Mice; Mice, Inbred BALB C | 2015 |
Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.
Topics: A549 Cells; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chitosan; Cisplatin; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Female; Humans; Lung Neoplasms; Mad2 Proteins; Mice; Mice, Nude; Nanoparticles; RNA, Small Interfering; RNAi Therapeutics; Tissue Distribution | 2016 |
Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.
Topics: Administration, Inhalation; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Freeze Drying; Humans; Lung; Lung Neoplasms; Magnetics; Nanoparticles; Particle Size; Powders; Tumor Cells, Cultured | 2016 |
Chitosan-hyaluronan based 3D co-culture platform for studying the crosstalk of lung cancer cells and mesenchymal stem cells.
Topics: A549 Cells; Animals; Biomarkers, Tumor; Carcinogenesis; Cell Count; Cell Movement; Cell Size; Chitosan; Coculture Techniques; Culture Media, Conditioned; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Hyaluronic Acid; Lung Neoplasms; Mesenchymal Stem Cells; Neoplastic Stem Cells; Reproducibility of Results; Spheroids, Cellular; Xenograft Model Antitumor Assays; Zebrafish | 2016 |
Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chitosan; Drug Delivery Systems; Humans; Lung Neoplasms; Microscopy, Fluorescence; Nanoparticles; Paclitaxel; Particle Size; Polyethylene Glycols; Rats; Receptors, Transferrin; Spectroscopy, Fourier Transform Infrared; Tissue Distribution; Transferrin | 2016 |
Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Chitosan; Cisplatin; Drug Resistance, Neoplasm; ErbB Receptors; Gene Knockdown Techniques; Gene Silencing; Humans; Inhibitory Concentration 50; Lung Neoplasms; Mad2 Proteins; Mice; Nanoparticles; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2017 |
SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Cadherins; Cell Movement; Chitosan; Doxorubicin; Drug Carriers; HMGA2 Protein; Humans; Lung Neoplasms; Microscopy, Electron, Scanning; Nanoparticles; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Spectroscopy, Fourier Transform Infrared; Vimentin | 2016 |
Use of 5-Fluorouracil Loaded Micelles and Cisplatin in Thermosensitive Chitosan Hydrogel as an Efficient Therapy against Colorectal Peritoneal Carcinomatosis.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Chitosan; Cisplatin; Colorectal Neoplasms; Disease Models, Animal; Drug Liberation; Female; Fluorouracil; Hydrogel, Polyethylene Glycol Dimethacrylate; Immunohistochemistry; Injections; Ki-67 Antigen; Liver Neoplasms; Lung Neoplasms; Mice, Inbred BALB C; Micelles; Peritoneal Neoplasms; Rheology; Temperature | 2017 |
Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
Topics: A549 Cells; AC133 Antigen; Antineoplastic Agents; Biomarkers; Chitosan; Cisplatin; Colloids; Curcumin; Diarylheptanoids; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Humans; Kinetics; Lung Neoplasms; Nanoparticles; Neoplastic Stem Cells; Photoelectron Spectroscopy; Spectroscopy, Fourier Transform Infrared | 2016 |
Nanogold-Gallate Chitosan-Targeted Pulmonary Delivery for Treatment of Lung Cancer.
Topics: Antineoplastic Agents; Biocompatible Materials; Chitosan; Cisplatin; Drug Delivery Systems; Excipients; Folic Acid; Gallic Acid; Gold; Humans; Lung Neoplasms; Metal Nanoparticles | 2017 |
Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
Topics: A549 Cells; Animals; Biological Transport; Chitosan; Delayed-Action Preparations; Deoxycytidine; Drug Carriers; Drug Liberation; Folic Acid; Gemcitabine; Humans; Lung Neoplasms; Mice; Nanoparticles; Particle Size; Polyethylene Glycols; Tissue Distribution | 2017 |
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy.
Topics: Adjuvants, Immunologic; Animals; Antigen Presentation; Antigens; Cancer Vaccines; Cell Line, Tumor; Cell Proliferation; Chitosan; Dendritic Cells; Female; Gene Expression; Immunomodulation; Immunotherapy; Lung Neoplasms; Lymphoma; Mice; Mice, Inbred C57BL; Nanoparticles; Nanotechnology; Ovalbumin; Poly I-C; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 3; Transfection | 2016 |
Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells.
Topics: A549 Cells; Administration, Inhalation; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Chitosan; Curcumin; Doxorubicin; Drug Carriers; Drug Liberation; Elastin; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Microspheres; Particle Size; Solubility | 2017 |
Artificial Chemical Reporter Targeting Strategy Using Bioorthogonal Click Reaction for Improving Active-Targeting Efficiency of Tumor.
Topics: Azides; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Chitosan; Click Chemistry; Female; Humans; Lung Neoplasms; Nanoparticles | 2017 |
Electrochemical Detecting Lung Cancer-Associated Antigen Based on Graphene-Gold Nanocomposite.
Topics: Antigens, Neoplasm; Biosensing Techniques; Chitosan; Electrochemical Techniques; Gold; Graphite; Humans; Immunoassay; Lung Neoplasms; Metal Nanoparticles; Phosphopyruvate Hydratase; Spectrum Analysis | 2017 |
Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Compounding; Humans; Inhibitory Concentration 50; Kinetics; Lung Neoplasms; Micelles; Particle Size; Solubility; Stearic Acids | 2009 |
Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chitosan; Coumarins; Lactic Acid; Lung; Lung Neoplasms; Male; Mice; Nanoparticles; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties; Thiazoles | 2009 |
The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.
Topics: Base Sequence; Cations; Cell Line, Tumor; Chitosan; Chromatography, Gel; Chromatography, High Pressure Liquid; DNA Primers; Humans; Lactic Acid; Lung Neoplasms; Microscopy, Confocal; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymerase Chain Reaction; RNA, Antisense; Telomerase | 2009 |
[In vitro study on polyethylene glycol-chitosan copolymer as a gene delivery vector].
Topics: Adenocarcinoma; Cell Line, Tumor; Chitosan; Drug Carriers; Genetic Vectors; HeLa Cells; Humans; Lung Neoplasms; Nanoparticles; Particle Size; Plasmids; Polyethylene Glycols; Polymers; Transfection | 2008 |
Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Coumarins; Drug Carriers; Humans; Hydrogen-Ion Concentration; Lactic Acid; Lung; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Microscopy, Confocal; Nanoparticles; Neoplasm Transplantation; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity; Thiazoles; Xenograft Model Antitumor Assays | 2009 |
Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Gene Silencing; Genetic Vectors; Green Fluorescent Proteins; Humans; Lung Neoplasms; Polyethyleneimine; Polymers; Proto-Oncogene Proteins c-akt; RNA, Small Interfering | 2009 |
A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy.
Topics: Animals; Biological Assay; Cell Line, Tumor; Cell Proliferation; Chitosan; Drug Delivery Systems; Eye Proteins; Genetic Therapy; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Lung Neoplasms; Mice; Microscopy, Fluorescence; Nerve Growth Factors; Osteosarcoma; Phosphates; Rheology; Serpins; Solutions | 2009 |
The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
Topics: Administration, Inhalation; Aerosols; Animals; Chitosan; Drug Carriers; Folic Acid; Gene Silencing; Gene Targeting; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Polyethyleneimine; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Treatment Outcome | 2009 |
Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
Topics: Adenocarcinoma; Biological Transport, Active; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Clathrin; Coated Pits, Cell-Membrane; Dose-Response Relationship, Drug; Drug Carriers; Endocytosis; Humans; Hypertonic Solutions; Kinetics; Lactic Acid; Lung Neoplasms; Microscopy, Confocal; Nanospheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectrometry, Fluorescence; Surface Properties; Technology, Pharmaceutical; Temperature | 2009 |
In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Topics: Adhesiveness; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Glioblastoma; Half-Life; Humans; Inhibitory Concentration 50; Injections, Intravenous; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Prodrugs; Solubility; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2009 |
Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA.
Topics: Animals; Arginine; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Hemolysis; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Molecular Weight; Polyethylene Glycols; Polymers; RNA, Small Interfering | 2010 |
Bioactive polyelectrolyte multilayers: hyaluronic acid mediated B lymphocyte adhesion.
Topics: B-Lymphocytes; Carcinoma, Squamous Cell; Cell Adhesion; Chitosan; Electrolytes; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Lung Neoplasms; Nanoparticles; Osmolar Concentration; Surface Properties; Tumor Cells, Cultured | 2010 |
Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan.
Topics: Carbohydrate Conformation; Cell Line, Transformed; Cell Line, Tumor; Cell Survival; Chitosan; Drug Delivery Systems; Electrophoresis, Agar Gel; Gene Expression; Gene Silencing; Humans; Hyaluronic Acid; Lipids; Luciferases; Lung Neoplasms; Microscopy, Confocal; Molecular Sequence Data; RNA, Small Interfering; Sulfhydryl Compounds | 2010 |
Chitosan-interferon-β gene complex powder for inhalation treatment of lung metastasis in mice.
Topics: Administration, Inhalation; Animals; Cell Line, Tumor; Chitosan; Electrophoresis, Agar Gel; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; Interferon-beta; Luciferases, Firefly; Lung; Lung Neoplasms; Male; Mannitol; Mice; Mice, Inbred Strains; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Nucleic Acid Conformation; Plasmids; Powders; Survival Analysis; Time Factors; Treatment Outcome | 2011 |
Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitosan; Humans; Lomustine; Lung Neoplasms; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared | 2011 |
Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Chitosan; Deoxycytidine; Dextran Sulfate; Drug Carriers; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Lung Neoplasms; Microscopy, Electron, Scanning; Microspheres; Particle Size | 2011 |
Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2'-O-methyl-RNA.
Topics: Carcinoma, Non-Small-Cell Lung; Chitosan; Humans; Lactic Acid; Lung Neoplasms; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; RNA, Antisense; Telomerase; Tissue Culture Techniques | 2011 |
Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Carcinoma, Non-Small-Cell Lung; Cell Line; Chitosan; Drug Carriers; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Quaternary Ammonium Compounds; Xenograft Model Antitumor Assays | 2011 |
Optimization of a spray drying process to prepare dry powder microparticles containing plasmid nanocomplex.
Topics: Administration, Inhalation; Cell Line, Tumor; Chitosan; Desiccation; Green Fluorescent Proteins; Humans; Lung Neoplasms; Models, Statistical; Molecular Weight; Nanoparticles; Nanotechnology; Particle Size; Plasmids; Powders; Temperature; Transfection | 2012 |
Treatment of lung cancer via telomerase inhibition: self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2'-O-Methyl-RNA.
Topics: Cell Line, Tumor; Cell Membrane; Chitosan; Enzyme Inhibitors; Genetic Vectors; Humans; Lung Neoplasms; Nanoparticles; Nebulizers and Vaporizers; Oligonucleotides, Antisense; Polymers; RNA; Telomerase; Transfection | 2012 |
Targeted delivery of insoluble cargo (paclitaxel) by PEGylated chitosan nanoparticles grafted with Arg-Gly-Asp (RGD).
Topics: Animals; Cell Line, Tumor; Chitosan; Drug Carriers; Emulsions; Injections, Intravenous; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Nanoparticles; NIH 3T3 Cells; Oligopeptides; Paclitaxel | 2012 |
Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.
Topics: Animals; Cell Line, Tumor; Cell Survival; Chitosan; Coculture Techniques; Drug Carriers; Female; Humans; Lung Neoplasms; Magnetite Nanoparticles; Mice; Mice, Nude; Molecular Imaging; Nuclear Magnetic Resonance, Biomolecular; Oligopeptides; Ovarian Neoplasms; Particle Size; Polyethylene Glycols; Receptor, ErbB-2; Rhodamines; Tissue Distribution | 2012 |
Recapitulating tumour microenvironment in chitosan-gelatin three-dimensional scaffolds: an improved in vitro tumour model.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chitosan; Extracellular Matrix; Gelatin; Gene Expression Profiling; Humans; Immunohistochemistry; Lung Neoplasms; Models, Biological; Reactive Oxygen Species; Tissue Scaffolds; Tumor Microenvironment | 2012 |
Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.
Topics: Adsorption; Cell Line, Tumor; Chitosan; Diffusion; Doxorubicin; Humans; Lung Neoplasms; Nanocapsules; Silicon Dioxide; Stearic Acids | 2012 |
Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Disease Progression; DNA, Catalytic; Doxorubicin; Drug Combinations; Drug Compounding; Drug Delivery Systems; Drug Stability; Drugs, Investigational; Humans; Lung Neoplasms; Mice; Mice, Nude; Nanoparticles; Osteosarcoma; Xenograft Model Antitumor Assays | 2013 |
Nanofibrous mats coated by homocharged biopolymer-layered silicate nanoparticles and their antitumor activity.
Topics: Aluminum Silicates; Animals; Cell Survival; Cells, Cultured; Chitosan; Fibrosarcoma; Hemolysis; Humans; Hydrogen Bonding; Lung; Lung Neoplasms; Mice; Microscopy, Electron, Transmission; Minerals; Nanocomposites; Photoelectron Spectroscopy; Tumor Cells, Cultured; X-Ray Diffraction | 2013 |
[Study of the uptake of chitosan oligosaccharide nanoparticles by A549 cells].
Topics: Adenocarcinoma; Chitin; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Epithelial Cells; Humans; Lung Neoplasms; Nanotechnology; Oligosaccharides; Particle Size; Time Factors; Tumor Cells, Cultured | 2004 |
Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice.
Topics: Administration, Inhalation; Aerosols; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Survival; Chitosan; Genes, ras; Lung Neoplasms; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Neovascularization, Pathologic; RNA-Binding Proteins; Urocanic Acid | 2006 |
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Topics: Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Gene Silencing; Humans; Lung Neoplasms; Nanoparticles; Particle Size; RNA, Small Interfering | 2007 |
Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.
Topics: Angiogenesis Inhibitors; Animals; Bone Neoplasms; Cell Line, Tumor; Chitosan; Drug Compounding; Eye Proteins; Female; Genes, Reporter; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Nerve Growth Factors; Osteosarcoma; Particle Size; Plasmids; Serpins; Transfection | 2007 |
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
Topics: Alginates; Animals; Antineoplastic Agents; Apoptosis; Buffers; Cell Line, Tumor; Chitosan; Cisplatin; Dose-Response Relationship, Drug; Female; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Leukemia; Lung Neoplasms; Mice; Nanoparticles; Ovarian Neoplasms; Particle Size; Static Electricity | 2007 |
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
Topics: Cell Line, Tumor; Chitosan; Coated Materials, Biocompatible; Crystallization; DNA; Drug Carriers; Drug Compounding; Humans; Lactic Acid; Lung Neoplasms; Materials Testing; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; RNA, Antisense; Transfection | 2007 |
Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) mice.
Topics: Administration, Inhalation; Aerosols; Animals; Chitosan; Disease Models, Animal; Gene Deletion; Genes, ras; Genetic Vectors; Lung Neoplasms; Male; Mice; PTEN Phosphohydrolase; Urocanic Acid | 2008 |
Regioselective conjugation of chitosan with a laminin-related peptide, Tyr-Ile-Gly-Ser-Arg, and evaluation of its inhibitory effect on experimental cancer metastasis.
Topics: Animals; Antineoplastic Agents; Chitin; Chitosan; Laminin; Lung Neoplasms; Melanoma, Experimental; Mice; Oligopeptides | 1999 |